Literature DB >> 25600361

Antisaccades and executive dysfunction in early drug-naive Parkinson's disease: The discovery study.

Chrystalina A Antoniades1, Nele Demeyere2, Christopher Kennard1, Glyn W Humphreys2, Michele T Hu1,3.   

Abstract

BACKGROUND: Cognitive impairment is well recognized in Parkinson's disease (PD), but when it begins to develop is unclear. The aim of this study was to identify early signs of cognitive impairment along with abnormalities in saccadic behavior in newly diagnosed unmedicated PD patients.
METHODS: Nineteen drug-naive PD patients and 20 controls were examined using a battery of tests, including an antisaccade task, phonemic and semantic verbal fluencies, and a switching and rule finding task.
RESULTS: With simple tasks, no differences were found between the two groups. However, cognitive performance of the two groups diverged with more complex tasks, occurring independently of PD-related motor impairment. Patients exhibited higher antisaccadic error rates and switch costs in the task switching test, and performed significantly worse in the rule finding task.
CONCLUSIONS: Certain cognitive domains and saccadic parameters are already significantly impoverished in newly diagnosed Parkinson's patients, even before the initiation of medication.
© 2015 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  Parkinson's disease; antisaccades; executive function; eye movements; task switching

Mesh:

Year:  2015        PMID: 25600361     DOI: 10.1002/mds.26134

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  16 in total

Review 1.  Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders.

Authors:  Erin E Robertson; Deborah A Hall; Andrew R McAsey; Joan A O'Keefe
Journal:  Clin Neuropsychol       Date:  2016-08       Impact factor: 3.535

2.  Antisaccade errors reveal cognitive control deficits in Parkinson's disease with freezing of gait.

Authors:  Courtney C Walton; Claire O'Callaghan; Julie M Hall; Moran Gilat; Loren Mowszowski; Sharon L Naismith; James R Burrell; James M Shine; Simon J G Lewis
Journal:  J Neurol       Date:  2015-10-13       Impact factor: 4.849

Review 3.  Mechanisms of saccade suppression revealed in the anti-saccade task.

Authors:  Brian C Coe; Douglas P Munoz
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-04-19       Impact factor: 6.237

4.  Preservation of Eye Movements in Parkinson's Disease Is Stimulus- and Task-Specific.

Authors:  Jolande Fooken; Pooja Patel; Christina B Jones; Martin J McKeown; Miriam Spering
Journal:  J Neurosci       Date:  2021-11-30       Impact factor: 6.709

5.  Using Saccadometry with Deep Brain Stimulation to Study Normal and Pathological Brain Function.

Authors:  Chrystalina A Antoniades; James J FitzGerald
Journal:  J Vis Exp       Date:  2016-07-14       Impact factor: 1.355

6.  Pallidal Deep Brain Stimulation Improves Higher Control of the Oculomotor System in Parkinson's Disease.

Authors:  Chrystalina A Antoniades; Pedro Rebelo; Christopher Kennard; Tipu Z Aziz; Alexander L Green; James J FitzGerald
Journal:  J Neurosci       Date:  2015-09-23       Impact factor: 6.167

Review 7.  Vergence and Strabismus in Neurodegenerative Disorders.

Authors:  Sarah L Kang; Aasef G Shaikh; Fatema F Ghasia
Journal:  Front Neurol       Date:  2018-05-16       Impact factor: 4.003

Review 8.  Eye Movements in Parkinson's Disease and Inherited Parkinsonian Syndromes.

Authors:  Elena Pretegiani; Lance M Optican
Journal:  Front Neurol       Date:  2017-11-09       Impact factor: 4.003

Review 9.  The range and nature of non-motor symptoms in drug-naive Parkinson's disease patients: a state-of-the-art systematic review.

Authors:  Panagiotis Zis; Roberto Erro; Courtney C Walton; Anna Sauerbier; Kallol Ray Chaudhuri
Journal:  NPJ Parkinsons Dis       Date:  2015-07-09

Review 10.  Quantifying Motor Impairment in Movement Disorders.

Authors:  James J FitzGerald; Zhongjiao Lu; Prem Jareonsettasin; Chrystalina A Antoniades
Journal:  Front Neurosci       Date:  2018-04-11       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.